Gamma knife radiosurgery for multiple brain metastases from lung cancer. 2009

Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
Department of Neurosurgery, BioMedical Research Institute, Kyungpook National University Hospital 50, Samduk-2-ga, Jung-gu, Daegu 700-721, South Korea. nsdoctor@naver.com

The aim of this study was to compare the effectiveness of gamma knife radiosurgery (GKS) for the treatment of multiple brain metastases from lung cancer with that of whole brain radiation therapy (WBRT). Patients with multiple (2-20) brain metastases were divided into two groups for initial brain tumor management: a GKS group (14 patients) and a WBRT group (19 patients). The patients were stratified by gender, age, initial Karnofsky performance status score, control of the primary site, known extracranial metastases, number of brain metastases, diameter of the maximal lesion, chemotherapy, and recursive partitioning analysis (RPA) Class. The 6-month and 1-year overall survival rates were 64.3% and 47.7%, respectively, in the GKS group, and 42.1% and 10.5%, respectively, in the WBRT group. The median survival time was 32 weeks in the GKS group and 24 weeks in the WBRT group. The overall survival time in the GKS group was significantly longer than in the WBRT group (p=0.04). The univariate analysis suggests that survival was increased in both patients with a controlled primary tumor site and in the GKS group (p=0.03, 0.04). The use of GKS in patients with multiple brain metastases significantly improved patient survival compared to the employment of WBRT. When we assessed the subgroups, systemic disease control and GKS were significant variables by univariate analysis.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
November 2013, Journal of Korean Neurosurgical Society,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
October 2012, Journal of Korean Neurosurgical Society,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
November 2009, International journal of radiation oncology, biology, physics,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
January 2009, Progress in neurological surgery,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
December 2002, No to shinkei = Brain and nerve,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
September 2011, Journal of Korean Neurosurgical Society,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
January 2013, Acta neurochirurgica. Supplement,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
August 2017, Journal of medical imaging and radiation oncology,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
January 2016, British journal of neurosurgery,
Seong-Hyun Park, and Sung-Kyoo Hwang, and Dong-Hun Kang, and Sun-Ho Lee, and Jaechan Park, and Jeong-Hyun Hwang, and In-Suk Hamm, and Yeun-Mook Park
January 2005, Journal of neurosurgery,
Copied contents to your clipboard!